Revvity Inc.

Revvity Inc.

RVTY

Get informed when a big investor buys or sells

+ Follow
Market Cap$14.37B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Revvity Inc.Revvity Inc.61.30.22%3%50.5
$116.40

Target Price by Analysts

10.9% downsideRevvity Target Price DetailsTarget Price
$71.67

Current Fair Value

45.1% downside

Overvalued by 45.1% based on the discounted cash flow analysis.

Share Statistics

Market cap$14.37 Billion
Enterprise Value$16.69 Billion
Dividend Yield$0.28 (0.22%)
Earnings per Share$2.08
Beta1.07
Outstanding Shares111,746,000

Return

Return on Equity3.29%ROE
Return on Assets1.97%
Return on Invested Capital3.31%

Valuation & Multiples

P/E Ratio61.33P/E Ratio
PEG-1554.89PEG
Price to Sales5.02Price to Sales
Price to Book Ratio2.04Price to Book Ratio
Enterprise Value to Revenue5.73
Enterprise Value to EBIT46.88
Enterprise Value to Net Income70
Total Debt to Enterprise0.2
Debt to Equity0.46Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
August 4, 2026
EPS Estimate
$1.21
Average shareholder expectation
Revenue Estimate
$702.96 M
Average shareholder expectation

Next Earnings Call

Expected Date
October 26, 2026
EPS Estimate
$1.28
Average shareholder expectation
Revenue Estimate
$694.62 M
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.4904 1150.33%
Total Calls78,500 23.10%
Total Puts38,500 94.97%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %115.53% 12.30%
Total Invested$12.92B 27.68%
Investors Holding551 40.00%

ESG Score

No data

About Revvity Inc.

16,700 employees
CEO: Prahlad Singh

PerkinElmer enables scientists, researchers, and clinicians to address their most critical challenges across science and healthcare. With a mission focused on innovating for a healthier world, the company delivers unique solutions to ser...